No Data
No Data
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Bullish Integra LifeSciences Holdings Insiders Loaded Up On US$2.50m Of Stock
Integra LifeSciences Is Maintained at Hold by Truist Securities
Integra LifeSciences Is Maintained at Hold by Truist
Integra LifeSciences Price Target Raised to $32.00/Share From $25.00 by Truist Securities
Integra LifeSciences Price Target Raised to $32.00/Share From $25.00 by Truist
A Quick Look at Today's Ratings for Integra Lifesciences(IART.US), With a Forecast Between $26 to $48
On Jul 16, major Wall Street analysts update their ratings for $Integra Lifesciences(IART.US)$, with price targets ranging from $26 to $48.Morgan Stanley analyst Drew Ranieri maintains with a sell
Integra Lifesciences: Strategic Manufacturing Shifts Amid Supply Constraints – A Hold Rating Perspective
No Data
Money MoverOP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$